Ralf Schirrmacher
3801 University Street
Montreal, QC, Canada
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
EXPRESS: Kinetic modeling of the Tropomyosin Receptor Kinases radioligand [18F]TRACK in human brain with high-resolution positron emission tomography.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: June 19, 2026
Kinetic modeling of the tropomyosin receptor kinases radioligand [18F]TRACK in human brain with high-resolution positron emission tomography.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: June 19, 2026
New Synthetic Strategies Toward DFO*: Enhanced Yield and Purity of a Key Chelator for 89Zr Chemistry.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 30, 2026
Macropa Scaffold Expansion for Actinium-225 Chelation: A Synthetic Strategy, Labeling Kinetics, and Theoretical Calculations.
Journal: Inorganic chemistry
Published: April 29, 2026
Sugar Amino Acid Linkers for the Design of [18F]SiFA-PSMA Radioligands.
Journal: ChemMedChem
Published: April 27, 2026
Native PEG-PLGA Attenuates β-Amyloid Aggregation and Toxicity under In Vitro Conditions.
Journal: ACS chemical neuroscience
Published: November 17, 2025
Kinetic modelling and evaluation of the TrkA/B/C radioligand [18F]TRACK in the pig brain.
Journal: Nuclear medicine and biology
Published: September 27, 2025
Preclinical Evaluation of Stable Integrin αvβ3-Specific [198Au]Gold Nanoparticles for Tumor Therapy.
Preclinical Evaluation of Stable Integrin αvβ3-Specific [198Au]Gold Nanoparticles for Tumor Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 22, 2025
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Journal: EJNMMI radiopharmacy and chemistry
Published: August 28, 2025
Recent advances in tropomyosin receptor kinase (TRK) inhibitors: a 2023-2024 patent landscape review.
Journal: Expert opinion on therapeutic patents
Published: July 05, 2025
Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE and Monitoring with Somatostatin Receptor PET/CT in Patients with Advanced Differentiated Thyroid Carcinoma.
Journal: Molecular imaging and biology
Published: June 02, 2025
Head to head comparison of [18F]SiTATE versus [18F]DOPA-PET in patients with neuroendocrine tumors.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 29, 2025
Last Updated: 09/26/2026